Early pharmacokinetic evaluation of anti-tubercular treatment as a good indicator of treatment success in pulmonary tuberculosis patients on a retreatment regimen

IF 5.3 4区医学 Q1 PHARMACOLOGY & PHARMACY

Journal of Pharmaceutical Investigation Pub Date : 2022-05-29 DOI:10.1007/s40005-022-00577-9

A. Mohan, A. Bhatnagar, Tarang Gupta, Das Ujjalkumar, S. Kanswal, T. Velpandian, R. Guleria, U. Singh

引用次数: 0

查看原文本刊更多论文

早期药代动力学评价抗结核治疗作为肺结核患者再治疗方案治疗成功的良好指标

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Pharmaceutical Investigation Pharmacology, Toxicology and Pharmaceutics-Pharmaceutical Science

CiteScore

10.20

自引率

9.10%

发文量

期刊介绍： Journal of Pharmaceutical Investigation(J. Pharm. Investig.), the official journal of the Korean Society of Pharmaceutical Sciences and Technology, is an international, peer-reviewed journal that covers all pharmaceutical sciences, including engineering, regulatory, physicochemical, biological, and microbiological studies related to the conception, design, production, characterization and evaluation of pharmaceutical products and drug delivery systems. It is a bimonthly journal published in January, March, May, July, September, and November. All manuscript should be creative and informative for pharmaceutical scientists, and should contain advanced knowledge in clear and concise English. Articles in the following categories are published: Research articles, Notes, Information, and Reviews.(Formerly Journal of Korean Pharmaceutical Sciences: ISSN 0259-2347)